Clinical Trials in North Carolina

Showing 5801-5820 of 15,496 trials

Expanding Health System Intervention Through The Women, Infants and Children (WIC) Program Partnership

NCT05356338

Pilot test the health system-based intervention to improve family beverage choices and promote water consumption, engaging WIC nutritionists to augment the intervention with follow-up and counseling of families at regularly-scheduled WIC appointments in a small randomized trial among 30 WIC-enrolled families.

Obesity, Childhood

Wake Forest University Health Sciences20 participantsStarted May 2022

Winston-Salem, North Carolina, United States

COMPLETEDNA41 miles

Yoga for Caregivers and Persons With Dementia

NCT05103839

The purpose of this research is to determine the feasibility and acceptability of yoga classes for persons living with dementia (PLWD) and their care partners. A secondary aim of this study is to examine the impact of yoga on caregiver burden.

Dementia

Wake Forest University Health Sciences4 participantsStarted May 2022

Winston-Salem, North Carolina, United States

COMPLETEDPhase 141 miles

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

NCT02168140

This phase I trial studies the side effects and best dose of CPI-613 when given together with bendamustine hydrochloride in treating patients with relapsed or refractory T-cell non-Hodgkin lymphoma or Hodgkin lymphoma. CPI-613 may kill cancer cells by turning off their mitochondria, which are used by cancer cells to produce energy and are the building blocks needed to make more cancer cells. By shutting off mitochondria, CPI-613 may deprive the cancer cells of energy and other supplies needed to survive and grow. Drugs used in chemotherapy, such as bendamustine hydrochloride, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving CPI-613 with bendamustine hydrochloride may kill more cancer cells.

Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+14 more

Wake Forest University Health Sciences16 participantsStarted Sep 2014

Winston-Salem, North Carolina, United States • Philadelphia, Pennsylvania, United States

Expanding Health System Intervention Through The Women, Infants and Children (WIC) Program Partnership

Yoga for Caregivers and Persons With Dementia

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Find Trials by Condition in North Carolina

ELUCIDATE FFRct Study

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)

A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

A Study of LY3471851 in Participants With Psoriasis

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

Evaluating Two Multifocal Daily Disposable Contact Lenses

A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

Evaluation of the Safety and Efficacy of REBORN System for Lipolysis Treatment

A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)